Patents by Inventor Susan Finderup

Susan Finderup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • High osteocalcin microcrystalline hydroxyapatite for calcium supplement
    Patent number: 10744188
    Abstract: An improved manufacturing process produces microcrystalline hydroxyapatite with sustained gradual calcium release that avoids spiking in blood calcium levels. Although the improved material did not cause significant elevation of blood calcium, it was just as effective in promoting bone mineralization as conventional calcium supplements. In addition, the material has much higher levels of bone growth factors as compared to prior hydroxyapatite products.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: August 18, 2020
    Assignee: Waitaki Biosciences
    Inventors: Craig Lachlan McIntosh, Susan Finderup, Harold Garthwaite
  • HIGH OSTEOCALCIN MICROCRYSTALLINE HYDROXYAPATITE FOR CALCIUM SUPPLEMENT
    Publication number: 20180236039
    Abstract: An improved manufacturing process produces microcrystalline hydroxyapatite with sustained gradual calcium release that avoids spiking in blood calcium levels. Although the improved material did not cause significant elevation of blood calcium, it was just as effective in promoting bone mineralization as conventional calcium supplements. In addition, the material has much higher levels of bone growth factors as compared to prior hydroxyapatite products.
    Type: Application
    Filed: April 20, 2018
    Publication date: August 23, 2018
    Applicant: Waitaki Biosciences
    Inventors: Craig Lachlan McIntosh, Susan Finderup, Harold Garthwaite
  • High osteocalcin microcrystalline hydroxyapatite for calcium supplement
    Patent number: 9974841
    Abstract: An improved manufacturing process produces microcrystalline hydroxyapatrte with sustained gradual calcium release that avoids spiking in blood calcium levels. Although the improved material did not cause significant elevation of blood calcium, it was just as effective in promoting bone mineralization as conventional calcium supplements. In addition, the material has much higher levels of bone growth factors as compared to prior hydroxyapatite products.
    Type: Grant
    Filed: September 4, 2014
    Date of Patent: May 22, 2018
    Assignee: WAITAKI BIOSCIENCES
    Inventors: Craig Lachlan McIntosh, Susan Finderup, Harold Garthwaite
  • High Osteocalcin Microcrystalline Hydroxyapatite For Calcium Supplement
    Publication number: 20160228517
    Abstract: An improved manufacturing process produces microcrystalline hydroxyapatrte with sustained gradual calcium release that avoids spiking in blood calcium levels. Although the improved material did not cause significant elevation of blood calcium, it was just as effective in promoting bone mineralization as conventional calcium supplements. In addition, the material has much higher levels of bone growth factors as compared to prior hydroxyapatite products.
    Type: Application
    Filed: September 4, 2014
    Publication date: August 11, 2016
    Applicant: Waitaki Biosciences
    Inventors: Craig Lachlan McIntosh, Susan Finderup, Harold Garthwaite